COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw ...

While RSV isn’t any more virulent than the cold, flu or COVID, the same precautions are recommended in order to control its ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

UPMC saw an increase in RSV cases in its health system, including in Lancaster County, a spokesperson said Jan. 7, especially ...

Among adults aged 75 and older, RSV was linked to a substantial burden of hospitalizations, ICU admissions, and in-hospital deaths before vaccines were available.

Over 160,000 people this season have landed in the hospital from flu complications, CDC estimates. More than 6,600 have died. Here are the symptoms.

Respiratory Syncytial Virus (RSV) is a highly contagious respiratory illness that primarily affects infants and older adults, ...

Respiratory Syncytial Virus, or RSV, is a common respiratory virus that causes mild, cold-like symptoms in most people, ...

U.S. surges of COVID-19, influenza, respiratory syncytial virus (RSV) and norovirus have collectively been dubbed a ...

A virus rapidly spreading in China is also circulating in the United States, causing concern among health experts.

In the throes of winter's yearly round of respiratory virus outbreaks, it pays to remember what Grandma told you.